Phase I Clinical Trial of Quadrivalent Influenza Virus Split Vaccine

Clinical trial NCT06622590 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06622590
Sponsor: Institute of Medical Biology, Chinese Academy of Medical Sciences
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Influenza, Human Influenza a Influenza Type B Influenza Viral Infections

Start date: 2024-10-13
Primary completion: 2025-01-09
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.